Providing nearly 700 products to patients worldwide
We create high-quality, affordable generic medicines, and make them accessible to people who need them. We have a broad product range and a growing pipeline of new medicines for treating a wide range of diseases. Therapeutic categories include anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory.
~700
Products on the market
50+
Countries
3
Distinct businesses
Related news
Hikma launches Daunorubicin HCl Injection
18 July 2018
Hikma launches Bleomycin for Injection, USP
18 July 2018